治疗过程比我想象中温和100倍！敷20分钟麻药后，操作全程不到半小时，探头在脸上只有温热的触 感，偶尔有轻微刺痛，像被小绒毛轻轻扎了一下，完全能忍。结束后护士立刻给我敷上高保湿修复冰 膜，还贴心打包了医用修复霜和防晒，叮嘱我前三天别用热水洗脸、避免暖气直吹。 冬季干敏皮+黄褐斑真的是地狱难度！去年冬天我踩的坑能写一本血泪史：暖气房里脸干到起皮，用手 指一搓全是皮屑，粉底根本挂不住；但颧骨的黄褐斑反而越捂越重，从浅褐色变成深咖色，鼻翼泛红刺 痛到连温和的氨基酸洁面都不敢用。 跟风买的某网红修复精华、千元保湿套盒堆了一桌子，最坑的是那款号称"淡斑神器"的美白精华，上脸 刺痛到飙泪，用了半瓶斑没淡就算，红血丝还多了两条，粉底一上直接斑驳卡粉，出门只能戴口罩遮 丑，那段时间连自拍都没勇气打开原相机。 就在我准备放弃淡斑、专心修复屏障时，在韩国做医美翻译的闺蜜甩来一张她的素颜照——她之前也是 干敏皮+雀斑，现在皮肤又白又润，斑点几乎隐形。追问之下才知道，她是在VelyB医院釜山西面店做 的Revlite SI淡斑，说这家连锁机构常年霸榜韩国医美满意度榜单，医生资质全公示，安全性拉满。 抱着"最后试一次"的心态飞了趟釜山 ...

Core Viewpoint - The article discusses the increasing popularity of cosmetic procedures among older adults, particularly as the Chinese New Year approaches, emphasizing the importance of safety and health in aesthetic pursuits [1][3]. Group 1: Trends in Cosmetic Procedures - There is a notable rise in older individuals, particularly those over 50, seeking cosmetic enhancements, often accompanied by friends or family [3][4]. - Popular procedures include minimally invasive options like facial lifts and eyelid rejuvenation, which not only improve appearance but also enhance quality of life [4][5]. - Non-surgical treatments such as injectables and light therapy are gaining traction, especially before festive seasons, due to their quick recovery times [7][9]. Group 2: Safety and Professional Guidance - Medical professionals stress the importance of prioritizing health and safety over aesthetic desires, advising against unrealistic expectations and excessive procedures [5][9]. - There are warnings about the risks associated with unregulated cosmetic practices, including severe skin damage from improper use of home beauty devices [9][10]. - Patients are encouraged to maintain realistic expectations and to consider long-term skincare and health habits rather than seeking immediate results through multiple procedures [10][11]. Group 3: Recommendations for Aesthetic Treatments - It is advised that individuals plan for recovery time when scheduling cosmetic procedures, especially before events like travel [9][10]. - The article highlights the importance of individualized treatment plans for issues like pigmentation, emphasizing that not all skin concerns can be resolved with a single treatment [7][9]. - Professionals recommend a balanced approach to cosmetic enhancements, suggesting that less frequent treatments may yield better long-term results [10][11].

Summary of Conference Call on Medical Aesthetics Industry Industry Overview - The medical aesthetics industry experienced fluctuations in data and trends from the second half of last year to January this year, with overall GMV and revenue slowing down after the second quarter, particularly showing negative growth in the third quarter, but recovering in the fourth quarter [1][2] - The growth in customer traffic is primarily driven by returning customers, with an increase in the proportion of new customers, especially among the younger demographic [2][4] Key Insights - **Revenue Trends**: The industry saw a 5% revenue growth in 2025 compared to 2020, with a 9% increase in customer traffic, although the average transaction value decreased by 4% [3][21] - **Quarterly Performance**: Q4 showed significant revenue growth of 10%, compensating for the low growth in Q2 and Q3, with January's revenue growth exceeding 10% [3][21] - **Customer Composition**: The proportion of returning customers increased from 52% to 58%, with new customer growth driven by new product launches and promotional activities [5][25] - **Product Growth**: New products, particularly botulinum toxin and collagen products, especially recombinant collagen, show growth potential [2][21] Tax Policy Impact - The adjustment of the VAT policy, with medical aesthetics services now subject to a 6% VAT, has impacted industry costs, although institutions are adopting strategies to mitigate this burden [10][28] - The termination of the medical aesthetics tax refund policy in South Korea is expected to benefit the domestic market, as it may encourage consumers to choose local services over traveling abroad [11][29] Product Line Analysis - **Botulinum Toxin Sales**: Sales of botulinum toxin products grew by 25% in 2023 compared to 2022, with a projected growth of 10% in 2025 [6][27] - **Collagen Products**: Sales of collagen products showed varied performance, with some brands experiencing significant growth, such as a 55% increase in sales for certain products in 2025 [12][29] - **Market Acceptance**: New botulinum products are well-received in the market, with institutions willing to adopt them due to their cost-effectiveness and ease of use [8][27] Competitive Landscape - The competition among leading medical aesthetics institutions is intensifying, with varying revenue trends observed among them [4][21] - The market is seeing a trend towards consolidation, with expectations of increased concentration in the industry as smaller institutions may struggle to compete [18][33] Future Outlook - The industry is expected to continue evolving with a focus on light medical aesthetics and increased institutional concentration, prompting companies to adjust their business strategies accordingly [2][21] - The introduction of new products and promotional strategies is anticipated to drive growth, with a target of achieving a 15% growth rate in 2026 [17][31] Additional Considerations - The acceptance and market potential of PDRN salmon needle products are being closely monitored, with expectations for rapid growth following regulatory approvals [14][30] - The overall market dynamics indicate a shift towards more standardized services and data-driven customer management, which may further influence the competitive landscape [33]

Core Viewpoint - Jiangsu Wuzhong is divesting its wholly-owned subsidiary, Shanghai Wuzhong Meixue Biotechnology, for 80 million yuan, indicating a strategic shift to focus on its core pharmaceutical business and reduce investment in the medical aesthetics sector [1][2]. Group 1: Company Actions and Strategy - Jiangsu Wuzhong plans to transfer 100% equity of Shanghai Wuzhong Meixue to Shanghai Qingyu Biotechnology for 80 million yuan, based on the subsidiary's asset valuation [1]. - The company confirmed a reduction in R&D investment in the medical aesthetics segment, aiming to concentrate on its pharmaceutical core business [1][2]. - The medical aesthetics division, established in 2021, has a sales team of 55 covering 537 medical aesthetic institutions [3]. Group 2: Financial Performance - The medical aesthetics segment generated 3.3 billion yuan in revenue in 2024, a staggering increase of 4225.65% year-on-year, contributing 20% to Jiangsu Wuzhong's total revenue of 16 billion yuan [4]. - The company had previously secured exclusive distribution rights for the AestheFill product until August 2032, which significantly boosted revenue [3][4]. Group 3: Legal and Regulatory Issues - Jiangsu Wuzhong is currently involved in arbitration with REGEN over a breach of the exclusive distribution agreement, seeking to confirm the validity of the agreement and potential damages of 1.6 billion yuan [6]. - The company faces reputational damage due to allegations of securities law violations, which have impacted the sales of AestheFill in mainland China [5][6]. Group 4: Historical Context - Jiangsu Wuzhong's stock was delisted on December 31, 2025, due to inflated revenue figures totaling 1.8 billion yuan over four years, which constituted about 20% of reported income during that period [7].

Core Viewpoint - The article highlights the deceptive practices in the medical beauty industry, particularly the use of "actors" to manipulate consumers into purchasing high-priced services through emotional manipulation and false endorsements [1][9]. Group 1: Consumer Manipulation Tactics - Medical beauty institutions employ "actors" who are familiar to the consumers, such as friends or acquaintances, to create a sense of trust and manipulate them into purchasing expensive beauty treatments [1][12]. - Consumers are often introduced to high-priced services through persuasive tactics, including showcasing before-and-after photos and creating a sense of urgency with limited-time offers [2][3]. - The use of psychological tactics, such as creating anxiety about appearance, is prevalent, with staff using phrases that suggest physical flaws will lead to negative life outcomes [3][4]. Group 2: Financial Deception - Consumers are frequently encouraged to take out loans for treatments without being fully informed about the terms, including high-interest rates, which can reach up to 23.99% annually [6][5]. - The process of signing loan agreements is often rushed, with consumers not being made aware of the details or implications of the contracts they are signing [5][6]. - Many consumers find themselves trapped in repayment plans for loans they did not fully understand, leading to ongoing financial burdens [6][9]. Group 3: Regulatory Violations - The article points out that many medical beauty institutions operate without proper licenses or fail to meet the legal requirements for medical practitioners, which is a violation of regulations [11][12]. - There is a lack of transparency regarding the qualifications of medical staff and the materials used in procedures, which poses significant risks to consumers [6][12]. - The article emphasizes the need for informed consent from patients, which is often neglected in these deceptive practices [12].

Group 1 - The core viewpoint of the article is that Suning Universal (000718) is actively developing its medical beauty business and plans to expand its operations based on business needs [1] Group 2 - The company has established medical beauty institutions in several locations, including Nanjing, Shanghai, and Wuxi in the East China region, as well as Shijiazhuang, Tangshan, and Beijing in the North China region [1] - The company emphasizes the importance of the medical beauty business and is committed to orderly expansion of its business footprint in the future [1]

Core Viewpoint - Recently, Ruiley Medical Beauty announced a subscription agreement with Miao Shi Aesthetics, investors, shareholders, and the target company, Laili Medical Beauty, indicating a strategic move to expand its business in Hong Kong and enhance financial performance through synergies [1] Group 1: Subscription Agreement Details - Ruiley Medical Beauty's indirect non-wholly owned subsidiary will subscribe for 170,000 shares of Laili Medical Beauty for HKD 2.55 million, acquiring a 51.0% stake [1] - Bifu Limited will subscribe for 63,300 shares for HKD 0.95 million, holding a 19.0% stake, while Miao Shi Aesthetics will hold a 30.0% stake [1] - Following the completion of the agreement, Laili Medical Beauty will become an indirect non-wholly owned subsidiary of Ruiley Medical Beauty, with its financial performance consolidated into the group’s accounts [1] Group 2: Business Strategy and Expectations - The board believes that the subscription aligns with the group's business expansion strategy and presents an opportunity to enhance operations in Hong Kong [1] - The expected improvement in the operational and financial performance of the target company could provide potential investment returns for the group [1]

Group 1 - A counterfeit currency crime gang was dismantled in Jiangcheng, which is linked to the "outstanding entrepreneur" Gao Tianyu [1] - Gao Tianyu's company, New Universe Group, promotes a retirement investment project with an annualized return of up to 20%, targeting elderly individuals with low-risk, high-return promises [1] - The company also markets medical beauty projects and beauty loan financial products, attracting young female students who later become involved in money laundering activities [1] Group 2 - The "beauty loan" scheme, depicted in the micro-drama, highlights the real-life financial traps faced by students, who are often lured by low or zero-interest promotions [2][3] - Legal experts indicate that many beauty institutions mislead consumers about the true costs of loans, with some advertising low monthly rates that translate to high annualized rates [2][3] - The hidden nature of loan agreements often leads consumers to unknowingly engage with unlicensed lending platforms [3] Group 3 - The micro-drama illustrates how live streaming can be used as a tool for money laundering, with a character receiving large donations that are actually proceeds from crime [5][6] - A real case involved a live streamer receiving nearly 50 million yuan in donations, which were later returned to the original source as part of a money laundering scheme [5][6] - The police have identified a network where live streaming donations are used to obscure the origins of illicit funds, complicating law enforcement efforts [6] Group 4 - The illegal fundraising schemes targeting the elderly, as shown in the micro-drama, reflect a growing trend in economic crimes, with many cases involving promises of high returns on retirement investments [7] - Recent statistics indicate that over 80% of victims in these schemes are elderly individuals, with the amounts involved ranging from hundreds of thousands to billions of yuan [7] - Common tactics include emotional appeals and high-return promises, which exploit the financial vulnerabilities of older adults [7] Group 5 - The micro-drama serves as an innovative approach to educate the public about new forms of economic crime, aiming to reach younger audiences through engaging storytelling [8][9] - The production team emphasizes the need for societal involvement in combating economic crime and encourages the public to report suspicious activities [8][9] - The overall message stresses the importance of avoiding high-yield temptations and choosing legitimate financial products [8][9]

Core Viewpoint - The article highlights the deceptive practices in the beauty and medical aesthetics industry, where consumers are lured into expensive treatments through manipulative tactics, leading to significant financial loss and dissatisfaction with results [2][3][4][5]. Group 1: Deceptive Practices - Beauty salons and medical aesthetic institutions are described as setting traps for consumers, turning the journey to beauty into a nightmare [2]. - The first tactic involves "room sharing," where a technician arranges for a "regular customer" to share a treatment room with the consumer, creating a false sense of trust and urgency [2][3]. - The second tactic includes staged conversations in waiting areas, where actors feign familiarity and satisfaction with the services to further persuade the consumer [3][4]. Group 2: Financial Manipulation - Consumers are often presented with high-priced treatment options, with initial quotes reaching up to 160,000 yuan, which are then "discounted" to create a false sense of value [5]. - The use of financial manipulation is evident, as consumers are encouraged to take out loans to afford treatments, with one case showing a consumer being approved for a loan of 70,000 yuan on the spot [5]. - Post-treatment, consumers face continuous upselling of additional services, leading to total expenditures exceeding 89,000 yuan without clear documentation of the procedures performed [5].

Group 1 - The establishment of the Endoscopic Aesthetic Surgery Professional Committee at Meilai Medical in Sichuan aims to integrate resources, promote technical standards and innovation, and enhance clinical applications in breast surgery [1] - The committee will focus on technical discussions, talent training, and standard formulation to support the systematic development of endoscopic aesthetic technology [1] - This initiative marks a milestone in Meilai's discipline construction and aims to provide customers with a safer and more effective aesthetic medical experience [1] Group 2 - Meilai Medical held an academic training session on endoscopic and ultrasound knife techniques, featuring a live demonstration of surgical processes and key technical details by Xiong Meng [3] - Xiong Meng delivered a presentation on "Subfascial Breast Augmentation - A New Path for Implant Augmentation," analyzing the advantages of combining these techniques based on over 30 years of clinical experience [3] - Since introducing endoscopy in 2014 and establishing a clinical application base for digital endoscopic breast augmentation in 2015, Meilai Medical continues to focus on discipline construction to provide high-quality aesthetic services [3]